<DOC>
	<DOC>NCT02209337</DOC>
	<brief_summary>A prospective, single arm, pre-market, multi-center clinical study to evaluate the safety and performance of the SRS (Lyra Medical) vaginal mesh in POP patients</brief_summary>
	<brief_title>Demonstrate the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Uterine Prolapse</mesh_term>
	<criteria>1. Patient has signed the informed consent form and is willing to participate in the clinical study and data collection. 2. Patient age is between 18 and 75 years old 3. POPQ: Aa and/or Ba is at least 1 1. Patient is pregnant or breastfeeding 2. Patient suffering from active infection (on antibiotic therapy) 3. Patient planning vaginal delivery 4. Patient had Previous vaginal mesh surgery 5. Patient is in high risk for surgery (evidence of clinically significant cardiovascular, renal, hepatic or respiratory diseases). 6. Any condition that in the judgment of the investigators would interfere with the subject's ability to provide informed consent, comply with study instructions, place the subject at increased risk, or which might confound interpretation of study results. 7. Malignancy . 8. Known hypersensitivity to PEEK and polypropylene materials. 9. Participation in another investigational trial that has not completed the primary endpoint or interferes with study participation.</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>